Heron Therapeutics, Inc./DE – ‘10-Q’ for 3/31/16 – ‘EXCEL’

On:  Thursday, 5/5/16, at 4:20pm ET   ·   For:  3/31/16   ·   Accession #:  1193125-16-579939   ·   File #:  1-33221

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    316K 
 2: EX-10.1     Material Contract                                   HTML     62K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
12: R1          Document And Entity Information                     HTML     39K 
13: R2          Condensed Consolidated Balance Sheets (Current      HTML     73K 
                Period Unaudited)                                                
14: R3          Condensed Consolidated Statements of Comprehensive  HTML     43K 
                Loss (Unaudited)                                                 
15: R4          Condensed Consolidated Statements of Cash Flows     HTML     72K 
                (Unaudited)                                                      
16: R5          Note 1 - Business                                   HTML     24K 
17: R6          Note 2 - Basis of Presentation                      HTML     18K 
18: R7          Note 3 - Accounting Policies                        HTML     42K 
19: R8          Note 4 - Fair Value Measurements                    HTML     51K 
20: R9          Note 5 - Convertible Notes to Related Parties       HTML     23K 
21: R10         Note 6 - Stockholders' Equity                       HTML     67K 
22: R11         Note 7 - Income Taxes                               HTML     19K 
23: R12         Significant Accounting Policies (Policies)          HTML     65K 
24: R13         Note 3 - Accounting Policies (Tables)               HTML     23K 
25: R14         Note 4 - Fair Value Measurements (Tables)           HTML     38K 
26: R15         Note 6 - Stockholders' Equity (Tables)              HTML     57K 
27: R16         Note 1 - Business (Details Textual)                 HTML     19K 
28: R17         Note 3 - Accounting Policies (Details Textual)      HTML     15K 
29: R18         Note 3 - Equity Excluded From Calculation of        HTML     21K 
                Diluted Earnings Per Share (Details)                             
30: R19         Note 4 - Fair Value Measurements (Details Textual)  HTML     24K 
31: R20         Note 4 - Financial Assets Measured on a Recurring   HTML     28K 
                Basis (Details)                                                  
32: R21         Note 5 - Convertible Notes to Related Parties       HTML     56K 
                (Details Textual)                                                
33: R22         Note 6 - Stockholders' Equity (Details Textual)     HTML     52K 
34: R23         Note 6 - Allocation of the Recognized Cost          HTML     23K 
                (Details)                                                        
35: R24         Note 6 - Option Valuation Assumptions (Details)     HTML     23K 
36: R25         Note 6 - Option Summary (Details)                   HTML     36K 
38: XML         IDEA XML File -- Filing Summary                      XML     59K 
37: EXCEL       IDEA Workbook of Financial Reports                  XLSX     33K 
 6: EX-101.INS  XBRL Instance -- hrtx-20160331                       XML    462K 
 8: EX-101.CAL  XBRL Calculations -- hrtx-20160331_cal               XML     62K 
 9: EX-101.DEF  XBRL Definitions -- hrtx-20160331_def                XML    415K 
10: EX-101.LAB  XBRL Labels -- hrtx-20160331_lab                     XML    398K 
11: EX-101.PRE  XBRL Presentations -- hrtx-20160331_pre              XML    434K 
 7: EX-101.SCH  XBRL Schema -- hrtx-20160331                         XSD     72K 
39: ZIP         XBRL Zipped Folder -- 0001193125-16-579939-xbrl      Zip     60K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Heron Therapeutics, Inc./DE       10-K       12/31/23   72:10M                                    Donnelley … Solutions/FA
 3/29/23  Heron Therapeutics, Inc./DE       10-K       12/31/22   73:12M                                    Donnelley … Solutions/FA
 2/28/22  Heron Therapeutics, Inc./DE       10-K       12/31/21   74:12M                                    ActiveDisclosure/FA
 2/24/21  Heron Therapeutics, Inc./DE       10-K       12/31/20   74:12M                                    ActiveDisclosure/FA